Company Financials

Krystal Biotech, Inc. Financials

United States dollar

business Krystal Biotech, Inc. Company Profile

Main Stock Listing

NASDAQ: KRYS

Market Capitalization $7.16 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 37.02
Forward PE 29.75
Price to Sales TTM $19.19
Price to Book MRQ $6.29
Enterprise to Revenue 17.25
Enterprise to EBITDA 40.32

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 53.30%
Operating Margin 42.31%
Return on Assets TTM 8.91%
Return on Equity TTM 19.66%

Income Statement

Revenue TTM $373,164,000
Revenue per Share TTM $12.93
Quarterly Revenue Growth 16.60%
Gross Profit TTM $351,758,016
EBITDA $164,581,000
Net Income to Common TTM $198,910,000
Diluted EPS TTM $6.67
Quarterly Earnings Growth YoY 192.00%

Balance Sheet

Total Cash MRQ $731,068,992
Total Cash per Share MRQ $25.21
Total Debt MRQ $
Total Debt to Equity MRQ 0.84
Current Ratio MRQ 10.14
Book Value per Share MRQ $39.26

Cash Flow

Operating Cash Flow TTM $176,200,000
Levered Free Cash Flow TTM $76,197,872

KRYS Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 28,984,000
Float Shares 22,881,362
Avg 10 Volume 251,350
Avg 30 Volume None
Shares Short 2,720,726
Short Ratio 9.30
Short % of Shares 15.70%
% Held by Insiders 11.65%
% Held by Institutions 99.30%

Stock Price Summary

Beta 0.48
Fifty Two Week Low $122.80
Fifty Two Week High $265.92
Fifty Two Week Change 36.90%
Day 50 MA $217.29
Day 200 MA $170.15

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date